Skip to main content

Day: March 27, 2024

Mawson Infrastructure Group Expands Co-Location Business

30% Growth in Total Co-Location Services Business to about 25,284 Miners or about 82 MW Increases Co-Location Services Business by about 5,880 Miners or About 20 MW Expands Enterprise Customer Co-Location Agreement after 3 Consecutive Co-Location Customer Agreements Executed and Implemented since the start of Q4, 2023 MIDLAND, Pa., March 27, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced that it has expanded its co-location business. Rahul Mewawalla, CEO and President, commented, “We are very pleased to increase and grow our co-location services business. After successfully executing and implementing three consecutive co-location customer agreements since the start of Q4, 2023, we are delighted that we have further expanded our enterprise...

Continue reading

Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023

Revenue of $67.2 million for the year and $18.4 million for the 4th quarter; Adj. EBITDA of $11.5 million for the year and $3.7 million for the quarter BEVERLY, Mass. and TORONTO, March 27, 2024 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter and year-ended December 31, 2023. Financial HighlightsSales for the year increased 16% to $67.2 million; sales for the quarter increased 12% to $18.4 million; sales increased 14% for the year and 8% for the quarter on a constant currency basis Organic sales growth was approximately 9% for the year and 7% for the quarter Gross profit margin...

Continue reading

UniFirst Announces Financial Results for the Second Quarter of Fiscal 2024

WILMINGTON, Mass., March 27, 2024 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its second quarter ended February 24, 2024 as compared to the corresponding period in the prior fiscal year: Q2 2024 Financial HighlightsConsolidated revenues for the second quarter increased 8.8% to $590.7 million. Operating income was $27.9 million, an increase of 34.9%. The quarterly tax rate increased to 26.2% compared to 24.6% in the prior year. Net income increased to $20.5 million from $17.8 million in the prior year, or 14.9%. Diluted earnings per share increased to $1.09 from $0.95 in the prior year, or 14.7%. EBITDA increased to $62.5 million compared to $50.5 million in the prior year, or 23.8%.The Company’s financial results for the second quarter of fiscal 2024...

Continue reading

Vantage Drilling International Ltd. Reports Fourth Quarter and Full-Year 2023 Results

DUBAI, United Arab Emirates, March 27, 2024 (GLOBE NEWSWIRE) — Vantage Drilling International Ltd. (“Vantage” or the “Company”) reported a net loss attributable to controlling interest of approximately $14.6 million, or $1.10 per diluted share, for the three months ended December 31, 2023, as compared to a net loss attributable to controlling interest of $16.4 million, or $1.25 per diluted share, for the three months ended December 31, 2022. For the year ended December 31, 2023, Vantage reported a net loss attributable to controlling interest of approximately $15.4 million or $1.16 per diluted share, as compared to a net loss attributable to controlling interest of $3.4 million or $0.26 per diluted share for the year ended December 31, 2022. As of December 31, 2023, Vantage had approximately $84.0 million in cash, including...

Continue reading

Calian Announces the Appointment of New President of Advanced Technologies

OTTAWA, March 27, 2024 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, is pleased to appoint Valérie Travain-Milone as President, Advanced Technologies (AT). Travain-Milone brings extensive leadership experience across GNSS, telecom, space, cybersecurity and digital services. Known for her purpose-driven approach and passion for technology, she has consistently nurtured teams towards success and growth. Holding an MBA in aerospace and with global experience in the Pacific, Europe and North America, her visionary leadership in per past role as CEO of Atos Canada fuelled the company’s expansion and accelerated revenue growth. “I am thrilled to welcome Valérie to the Calian team. With her global perspective...

Continue reading

Li Auto Inc. Announces Put Right Notification for 0.25% Convertible Senior Notes due 2028

BEIJING, March 27, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it is notifying holders of its 0.25% Convertible Senior Notes due 2028 (CUSIP No. 50202M AB8) (the “Notes”) that pursuant to the Indenture dated as of April 12, 2021 (the “Indenture”) relating to the Notes by and between the Company and Deutsche Bank Trust Company Americas, as trustee and paying agent, each holder has the right, at the option of such holder, to require the Company to purchase all of such holder’s Notes or any portion of the principal thereof that is equal to US$1,000 principal amount (or an integral multiple thereof) for cash on May 1, 2024 (the “Put Right”). The Put Right expires at 5:00 p.m., New York City time, on Monday, April 29, 2024. As required...

Continue reading

Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer

 The stenoparib Phase 2 monotherapy trial in advanced, recurrent ovarian cancer continues to show promise, prompting shift in resources to accelerate stenoparib development Further development of IXEMPRA® and dovitinib is de-prioritized The Company has been able to reduce costs materiallyBoston (March 27, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced a strategic pivot aimed at advancing its clinical-stage candidate stenoparib, a novel PARP/Tankyrase dual inhibitor, toward registration in advanced recurrent ovarian cancer, leveraging its DRP® platform to identify and enroll only the patients most likely to derive clinical benefit. This decision is the outcome of an extensive analysis of...

Continue reading

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17

Restatement of non-cash items is not expected to materially impact cash position or operations DENVER, March 27, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that it will restate its financial statements for the fiscal year ended December 31, 2022 and for the interim periods ended March 31, 2023, June 30, 2023 and September 30, 2023. The restatement will impact the accounting treatment and classification of certain outstanding warrants and the prepaid forward purchase arrangement that was terminated in June 2023. Due to the additional audit procedures involved in the restatement, SeaStar Medical expects to file Form 12b-25 with the Securities and Exchange...

Continue reading

Decklar Resources Updates Crude Oil Injection Volumes From the Oza Oil Field Through the Trans Niger Pipeline and Sales to Local Refinery

Decklar Resources Inc. and its co-venturer Millenium Oil & Gas Company Limited announce continued crude oil injection volumes from the Oza Oil Field through the Trans Niger Pipeline to the Bonny Export Terminal. Decklar and Millenium sell additional crude oil production from the Oza Oil Field to a local refinery in Edo State.CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) — Decklar Resources Inc. (TSX-V: DKL) (OTC: DKLRF) (FSE: A1U1) (the “Company” or “Decklar”) and its co-venturer Millenium Oil & Gas Company Limited (“Millenium”) are pleased to announce ongoing crude oil injection volumes into the Trans Niger Pipeline (“TNP”) for transport to and export from the Bonny Export Terminal from the Oza Oil Field and continued sales to a local refinery in Edo State. Delivery of Crude Oil from the Oza Oil Field Decklar...

Continue reading

Odysight.ai Announces 2023 Financial Results and Provides Corporate Update

Revenues increased in more than 350% from its commercial contracts OMER, Israel, March 27, 2024 (GLOBE NEWSWIRE) — Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions, announced financial results for the year ended December 31, 2023 and the filing of its annual report on Form 10-K for such year with the U.S. Securities and Exchange Commission. As of December 31, 2023, Odysight.ai had $17.0 million of cash and short-term deposits on its balance sheet. Key highlights:The Company reported revenues of $3.0 million in the year ended of December 31, 2023, compared to $0.7 million in year ended on December 31, 2022, an increase of more than 350%.The Company achieved a positive gross profit for the first time. Gross profit was $0.5 million for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.